Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan

AIM:To investigate the antioxidative status of patients with alcoholic liver disease(ALD) in southeastern Taiwan.METHODS:Our study comprised 27 patients with ALD recruited from Taitung Mackay Memorial Hospital,located in southeastern Taiwan.Patients with ALD included 12 non-aborigines(12 men) and 15...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 17; no. 8; pp. 1063 - 1070
Main Authors Chen, Ya-Ling, Chen, Li-Ju, Bair, Ming-Jong, Yao, Mei-Lan, Peng, Hsiang-Chi, Yang, Sien-Sing, Yang, Suh-Ching
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Co., Limited 28.02.2011
Subjects
Online AccessGet full text
ISSN1007-9327
2219-2840
2219-2840
DOI10.3748/wjg.v17.i8.1063

Cover

Abstract AIM:To investigate the antioxidative status of patients with alcoholic liver disease(ALD) in southeastern Taiwan.METHODS:Our study comprised 27 patients with ALD recruited from Taitung Mackay Memorial Hospital,located in southeastern Taiwan.Patients with ALD included 12 non-aborigines(12 men) and 15 aborigines(11 men and 4 women).According to the severity of ALD,patients with ALD included 10 with hepatitis(9 men and 1 woman) and 17 with cirrhosis(14 men and 3 women).Twenty-two age-and gender-matched healthy adultsserved as the control group in this study.Venous blood(10 mL) of each subject was drawn into EDTA-containing tubes after 8 h overnight fasting.RESULTS:Compared to the control group,patients with ALD showed significantly lower erythrocytic catalase(11.1 ± 0.7 U/mg Hb vs 8.0 ± 0.7 U/mg Hb,P 〈 0.05) and superoxide dismutase(9.5 ± 1.6 U/mg Hb vs 3.0 ± 0.2 U/mg Hb,P 〈 0.05) activities.Furthermore,the erythrocytic reduced glutathione/oxidized glutathione ratio was signif icantly lower in ALD patients than that in the control group(38.1 ± 5.4 vs 15.7 ± 1.9,P 〈 0.05).The results revealed that patients with ALD experienced more oxidative stress than those in the control group.The non-aboriginal,but not the aboriginal,ALD group had higher erythrocytic glutathione peroxidase(GPX) activity than that in the control group(46.1 ± 7.8 U/g Hb vs 27.9 ± 2.2 U/g Hb,P 〈 0.05).Hepatitis,but not cirrhosis,ALD patients had higher erythrocytic GPX activity than that in the control group(44.3 ± 8.6 U/g Hb vs 27.9 ± 2.2 U/g Hb,P 〈 0.05).CONCLUSION:Our results indicate that both ethnicity and the severity of ALD may cause different erythrocytic antioxidative enzyme activities especially GPX activity.
AbstractList To investigate the antioxidative status of patients with alcoholic liver disease (ALD) in southeastern Taiwan. Our study comprised 27 patients with ALD recruited from Taitung Mackay Memorial Hospital, located in southeastern Taiwan. Patients with ALD included 12 non-aborigines (12 men) and 15 aborigines (11 men and 4 women). According to the severity of ALD, patients with ALD included 10 with hepatitis (9 men and 1 woman) and 17 with cirrhosis (14 men and 3 women). Twenty-two age- and gender-matched healthy adults served as the control group in this study. Venous blood (10 mL) of each subject was drawn into EDTA-containing tubes after 8 h overnight fasting. Compared to the control group, patients with ALD showed significantly lower erythrocytic catalase (11.1 ± 0.7 U/mg Hb vs 8.0 ± 0.7 U/mg Hb, P < 0.05) and superoxide dismutase (9.5 ± 1.6 U/mg Hb vs 3.0 ± 0.2 U/mg Hb, P < 0.05) activities. Furthermore, the erythrocytic reduced glutathione/oxidized glutathione ratio was significantly lower in ALD patients than that in the control group (38.1 ± 5.4 vs 15.7 ± 1.9, P < 0.05). The results revealed that patients with ALD experienced more oxidative stress than those in the control group. The non-aboriginal, but not the aboriginal, ALD group had higher erythrocytic glutathione peroxidase (GPX) activity than that in the control group (46.1 ± 7.8 U/g Hb vs 27.9 ± 2.2 U/g Hb, P < 0.05). Hepatitis, but not cirrhosis, ALD patients had higher erythrocytic GPX activity than that in the control group (44.3 ± 8.6 U/g Hb vs 27.9 ± 2.2 U/g Hb, P < 0.05). Our results indicate that both ethnicity and the severity of ALD may cause different erythrocytic antioxidative enzyme activities especially GPX activity.
AIM:To investigate the antioxidative status of patients with alcoholic liver disease(ALD) in southeastern Taiwan.METHODS:Our study comprised 27 patients with ALD recruited from Taitung Mackay Memorial Hospital,located in southeastern Taiwan.Patients with ALD included 12 non-aborigines(12 men) and 15 aborigines(11 men and 4 women).According to the severity of ALD,patients with ALD included 10 with hepatitis(9 men and 1 woman) and 17 with cirrhosis(14 men and 3 women).Twenty-two age-and gender-matched healthy adultsserved as the control group in this study.Venous blood(10 mL) of each subject was drawn into EDTA-containing tubes after 8 h overnight fasting.RESULTS:Compared to the control group,patients with ALD showed significantly lower erythrocytic catalase(11.1 ± 0.7 U/mg Hb vs 8.0 ± 0.7 U/mg Hb,P 〈 0.05) and superoxide dismutase(9.5 ± 1.6 U/mg Hb vs 3.0 ± 0.2 U/mg Hb,P 〈 0.05) activities.Furthermore,the erythrocytic reduced glutathione/oxidized glutathione ratio was signif icantly lower in ALD patients than that in the control group(38.1 ± 5.4 vs 15.7 ± 1.9,P 〈 0.05).The results revealed that patients with ALD experienced more oxidative stress than those in the control group.The non-aboriginal,but not the aboriginal,ALD group had higher erythrocytic glutathione peroxidase(GPX) activity than that in the control group(46.1 ± 7.8 U/g Hb vs 27.9 ± 2.2 U/g Hb,P 〈 0.05).Hepatitis,but not cirrhosis,ALD patients had higher erythrocytic GPX activity than that in the control group(44.3 ± 8.6 U/g Hb vs 27.9 ± 2.2 U/g Hb,P 〈 0.05).CONCLUSION:Our results indicate that both ethnicity and the severity of ALD may cause different erythrocytic antioxidative enzyme activities especially GPX activity.
To investigate the antioxidative status of patients with alcoholic liver disease (ALD) in southeastern Taiwan.AIMTo investigate the antioxidative status of patients with alcoholic liver disease (ALD) in southeastern Taiwan.Our study comprised 27 patients with ALD recruited from Taitung Mackay Memorial Hospital, located in southeastern Taiwan. Patients with ALD included 12 non-aborigines (12 men) and 15 aborigines (11 men and 4 women). According to the severity of ALD, patients with ALD included 10 with hepatitis (9 men and 1 woman) and 17 with cirrhosis (14 men and 3 women). Twenty-two age- and gender-matched healthy adults served as the control group in this study. Venous blood (10 mL) of each subject was drawn into EDTA-containing tubes after 8 h overnight fasting.METHODSOur study comprised 27 patients with ALD recruited from Taitung Mackay Memorial Hospital, located in southeastern Taiwan. Patients with ALD included 12 non-aborigines (12 men) and 15 aborigines (11 men and 4 women). According to the severity of ALD, patients with ALD included 10 with hepatitis (9 men and 1 woman) and 17 with cirrhosis (14 men and 3 women). Twenty-two age- and gender-matched healthy adults served as the control group in this study. Venous blood (10 mL) of each subject was drawn into EDTA-containing tubes after 8 h overnight fasting.Compared to the control group, patients with ALD showed significantly lower erythrocytic catalase (11.1 ± 0.7 U/mg Hb vs 8.0 ± 0.7 U/mg Hb, P < 0.05) and superoxide dismutase (9.5 ± 1.6 U/mg Hb vs 3.0 ± 0.2 U/mg Hb, P < 0.05) activities. Furthermore, the erythrocytic reduced glutathione/oxidized glutathione ratio was significantly lower in ALD patients than that in the control group (38.1 ± 5.4 vs 15.7 ± 1.9, P < 0.05). The results revealed that patients with ALD experienced more oxidative stress than those in the control group. The non-aboriginal, but not the aboriginal, ALD group had higher erythrocytic glutathione peroxidase (GPX) activity than that in the control group (46.1 ± 7.8 U/g Hb vs 27.9 ± 2.2 U/g Hb, P < 0.05). Hepatitis, but not cirrhosis, ALD patients had higher erythrocytic GPX activity than that in the control group (44.3 ± 8.6 U/g Hb vs 27.9 ± 2.2 U/g Hb, P < 0.05).RESULTSCompared to the control group, patients with ALD showed significantly lower erythrocytic catalase (11.1 ± 0.7 U/mg Hb vs 8.0 ± 0.7 U/mg Hb, P < 0.05) and superoxide dismutase (9.5 ± 1.6 U/mg Hb vs 3.0 ± 0.2 U/mg Hb, P < 0.05) activities. Furthermore, the erythrocytic reduced glutathione/oxidized glutathione ratio was significantly lower in ALD patients than that in the control group (38.1 ± 5.4 vs 15.7 ± 1.9, P < 0.05). The results revealed that patients with ALD experienced more oxidative stress than those in the control group. The non-aboriginal, but not the aboriginal, ALD group had higher erythrocytic glutathione peroxidase (GPX) activity than that in the control group (46.1 ± 7.8 U/g Hb vs 27.9 ± 2.2 U/g Hb, P < 0.05). Hepatitis, but not cirrhosis, ALD patients had higher erythrocytic GPX activity than that in the control group (44.3 ± 8.6 U/g Hb vs 27.9 ± 2.2 U/g Hb, P < 0.05).Our results indicate that both ethnicity and the severity of ALD may cause different erythrocytic antioxidative enzyme activities especially GPX activity.CONCLUSIONOur results indicate that both ethnicity and the severity of ALD may cause different erythrocytic antioxidative enzyme activities especially GPX activity.
AIM: To investigate the antioxidative status of patients with alcoholic liver disease (ALD) in southeastern Taiwan. METHODS: Our study comprised 27 patients with ALD recruited from Taitung Mackay Memorial Hospital, located in southeastern Taiwan. Patients with ALD included 12 non-aborigines (12 men) and 15 aborigines (11 men and 4 women). According to the severity of ALD, patients with ALD included 10 with hepatitis (9 men and 1 woman) and 17 with cirrhosis (14 men and 3 women). Twenty-two age- and gender-matched healthy adults served as the control group in this study. Venous blood (10 mL) of each subject was drawn into EDTA-containing tubes after 8 h overnight fasting. RESULTS: Compared to the control group, patients with ALD showed significantly lower erythrocytic catalase (11.1 ± 0.7 U/mg Hb vs 8.0 ± 0.7 U/mg Hb, P < 0.05) and superoxide dismutase (9.5 ± 1.6 U/mg Hb vs 3.0 ± 0.2 U/mg Hb, P < 0.05) activities. Furthermore, the erythrocytic reduced glutathione/oxidized glutathione ratio was significantly lower in ALD patients than that in the control group (38.1 ± 5.4 vs 15.7 ± 1.9, P < 0.05). The results revealed that patients with ALD experienced more oxidative stress than those in the control group. The non-aboriginal, but not the aboriginal, ALD group had higher erythrocytic glutathione peroxidase (GPX) activity than that in the control group (46.1 ± 7.8 U/g Hb vs 27.9 ± 2.2 U/g Hb, P < 0.05). Hepatitis, but not cirrhosis, ALD patients had higher erythrocytic GPX activity than that in the control group (44.3 ± 8.6 U/g Hb vs 27.9 ± 2.2 U/g Hb, P < 0.05). CONCLUSION: Our results indicate that both ethnicity and the severity of ALD may cause different erythrocytic antioxidative enzyme activities especially GPX activity.
Author Ya-Ling Chen Li-Ju Chen Ming-Jong Bair Mei-Lan Yao Hsiang-Chi Peng Sien-Sing Yang Suh-Ching Yang
AuthorAffiliation School of Nutrition and HealthSciences, College of Public Health and Nutrition, Taipei MedicalUniversity, 250 Wu-Hsing Street, Taipei 110, Taiwan, China School of Pharmacy, Taipei Medical Univer-sity, 250 Wu-Hsing Street, Taipei 110, Taiwan, China Department of Nutrition, Mackay MemorialHospital (Taitung Branch), Chang-Sha street, Taitung 95054,Taiwan, China Division of Gastroenterology, Departmentof Internal Medicine, Mackay Memorial Hospital (TaitungBranch), Chang-Sha street, Taitung 95054, Taiwan China Department of Laboratory, Mackay MemorialHospital (Taitung Branch), Chang-Sha street, Taitung 95054,Taiwan, China Liver Unit, Cathay General Hospital, 280,Jen-Ai Road, Sec. 4, Taipei 106, Taiwan, China
Author_xml – sequence: 1
  givenname: Ya-Ling
  surname: Chen
  fullname: Chen, Ya-Ling
  organization: School of Nutrition and Health Sciences, College of Public Health and Nutrition, Taipei Medical University, Taiwan, China
– sequence: 2
  givenname: Li-Ju
  surname: Chen
  fullname: Chen, Li-Ju
– sequence: 3
  givenname: Ming-Jong
  surname: Bair
  fullname: Bair, Ming-Jong
– sequence: 4
  givenname: Mei-Lan
  surname: Yao
  fullname: Yao, Mei-Lan
– sequence: 5
  givenname: Hsiang-Chi
  surname: Peng
  fullname: Peng, Hsiang-Chi
– sequence: 6
  givenname: Sien-Sing
  surname: Yang
  fullname: Yang, Sien-Sing
– sequence: 7
  givenname: Suh-Ching
  surname: Yang
  fullname: Yang, Suh-Ching
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21448360$$D View this record in MEDLINE/PubMed
BookMark eNpVkD1PwzAQhi0Eoh8wsyEzMaX4bKd2FqSq4kuqxFLmyHWcxlVqt7HTwr8nqKWC6XR3j573dAN07rwzCN0AGTHB5cN-tRztQIysHAEZszPUpxSyhEpOzlEfCBFJxqjooUEIK0IoYym9RD0KnEs2Jn00n7ho_actVLQ7g0NUsQ3Yl3jTDYyLAe9trLCqta98bTWuO6zBhQ1GBYOtw8G3seqaaBqH58rulbtCF6Wqg7k-1iH6eH6aT1-T2fvL23QySzTNICaSgtJZWnCTybIwUoAqGIzLhVTAOGhDQVAwRKYqLQ3nIIVY6FJwzRUvF8CG6PHg3bSLtSl0d2-j6nzT2LVqvnKvbP5_42yVL_0uZyQVkP4I7o-Cxm9bE2K-tkGbulbO-DbkMs14JjiQjrz9G3XK-P1kB9wdAF15t9xatzwxTMgxpQTYN6QohdU
ContentType Journal Article
Copyright 2011 Baishideng Publishing Group Co., Limited. All rights reserved. 2011
Copyright_xml – notice: 2011 Baishideng Publishing Group Co., Limited. All rights reserved. 2011
DBID 2RA
92L
CQIGP
W91
~WA
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.3748/wjg.v17.i8.1063
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan
EISSN 2219-2840
EndPage 1070
ExternalDocumentID PMC3057151
21448360
37862201
Genre Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GroupedDBID ---
123
29R
2B.
2C~
2RA
2WC
36B
53G
5VR
8WL
92F
92I
92L
93N
93R
AAKDD
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CHBEP
CIEJG
CQIGP
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
EMB
F5P
FA0
FRP
GX1
HYE
M~E
OK1
P2P
RNS
RPM
SV3
TCJ
TGQ
TR2
W91
WFFXF
XSB
~WA
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c291t-821ac95d4e98fde871ad316fb8a1341ce21721e085a5fe441877bcf74c4a4fb13
ISSN 1007-9327
2219-2840
IngestDate Tue Sep 30 16:00:33 EDT 2025
Thu Jul 10 19:22:55 EDT 2025
Mon Jul 21 06:07:37 EDT 2025
Wed Feb 14 09:53:52 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 8
Keywords Cirrhosis
Hepatitis
Antioxidative status
Aborigines
Alcoholic liver disease
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c291t-821ac95d4e98fde871ad316fb8a1341ce21721e085a5fe441877bcf74c4a4fb13
Notes AIM:To investigate the antioxidative status of patients with alcoholic liver disease(ALD) in southeastern Taiwan.METHODS:Our study comprised 27 patients with ALD recruited from Taitung Mackay Memorial Hospital,located in southeastern Taiwan.Patients with ALD included 12 non-aborigines(12 men) and 15 aborigines(11 men and 4 women).According to the severity of ALD,patients with ALD included 10 with hepatitis(9 men and 1 woman) and 17 with cirrhosis(14 men and 3 women).Twenty-two age-and gender-matched healthy adultsserved as the control group in this study.Venous blood(10 mL) of each subject was drawn into EDTA-containing tubes after 8 h overnight fasting.RESULTS:Compared to the control group,patients with ALD showed significantly lower erythrocytic catalase(11.1 ± 0.7 U/mg Hb vs 8.0 ± 0.7 U/mg Hb,P 〈 0.05) and superoxide dismutase(9.5 ± 1.6 U/mg Hb vs 3.0 ± 0.2 U/mg Hb,P 〈 0.05) activities.Furthermore,the erythrocytic reduced glutathione/oxidized glutathione ratio was signif icantly lower in ALD patients than that in the control group(38.1 ± 5.4 vs 15.7 ± 1.9,P 〈 0.05).The results revealed that patients with ALD experienced more oxidative stress than those in the control group.The non-aboriginal,but not the aboriginal,ALD group had higher erythrocytic glutathione peroxidase(GPX) activity than that in the control group(46.1 ± 7.8 U/g Hb vs 27.9 ± 2.2 U/g Hb,P 〈 0.05).Hepatitis,but not cirrhosis,ALD patients had higher erythrocytic GPX activity than that in the control group(44.3 ± 8.6 U/g Hb vs 27.9 ± 2.2 U/g Hb,P 〈 0.05).CONCLUSION:Our results indicate that both ethnicity and the severity of ALD may cause different erythrocytic antioxidative enzyme activities especially GPX activity.
14-1219/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Correspondence to: Dr. Suh-Ching Yang, School of Nutrition and Health Sciences, Taipei Medical University, Taipei 110, Taiwan, China. sokei@tmu.edu.tw
Author contributions: Chen YL and Chen LJ contributed equally to this work; Chen YL, Chen LJ, Peng HC and Yao ML performed research and analyzed data; Bair MJ and Yang SS performed the diagnosis of alcoholic liver disease; Yang SC designed the research; Yang SS and Yang SC wrote the paper.
Telephone: +886-2-27361661 Fax: +886-2-27373112
PMID 21448360
PQID 859497410
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3057151
proquest_miscellaneous_859497410
pubmed_primary_21448360
chongqing_primary_37862201
PublicationCentury 2000
PublicationDate 2011-02-28
PublicationDateYYYYMMDD 2011-02-28
PublicationDate_xml – month: 02
  year: 2011
  text: 2011-02-28
  day: 28
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World Journal of Gastroenterology
PublicationYear 2011
Publisher Baishideng Publishing Group Co., Limited
Publisher_xml – name: Baishideng Publishing Group Co., Limited
References 9397995 - Hepatology. 1997 Dec;26(6):1538-45
9553600 - Postgrad Med. 1998 Apr;103(4):261-4, 267-8, 273-5
3258084 - Acta Psychiatr Scand. 1988 Jan;77(1):7-13
17520517 - Semin Liver Dis. 2007 May;27(2):173-93
11886428 - Eur J Clin Invest. 2002 Mar;32 Suppl 1:21-7
15670660 - Alcohol. 2004 Aug;34(1):9-19
3338721 - Hepatology. 1988 Jan-Feb;8(1):65-8
11966508 - Aliment Pharmacol Ther. 2002 May;16(5):985-92
12632815 - J Formos Med Assoc. 2002 Dec;101(12):826-34
8720922 - Free Radic Biol Med. 1996;20(3):483-8
9867111 - Scand J Gastroenterol Suppl. 1998;228:38-46
520102 - Dig Dis Sci. 1979 Nov;24(11):835-8
16377365 - Gen Hosp Psychiatry. 2006 Jan-Feb;28(1):48-54
3172971 - Life Sci. 1988;43(12):991-8
3997068 - Hepatology. 1985 May-Jun;5(3):367-75
9581686 - Hepatology. 1998 May;27(5):1317-23
6733615 - Can Med Assoc J. 1984 Jun 1;130(11):1445-7
15670669 - Alcohol. 2004 Aug;34(1):81-7
9021946 - Hepatology. 1997 Feb;25(2):351-5
8030604 - Am J Clin Nutr. 1994 Aug;60(2):255-61
1443441 - Alcohol Clin Exp Res. 1992 Oct;16(5):991-5
2169497 - J Infect Dis. 1990 Oct;162(4):817-22
2627239 - Alcohol Alcohol. 1989;24(6):503-7
18007552 - Ann Hepatol. 2007 Oct-Dec;6(4):227-32
8412153 - J Stud Alcohol. 1993 Sep;54(5):626-9
9875551 - Semin Liver Dis. 1998;18(4):313-29
8610707 - Am J Epidemiol. 1996 May 1;143(9):936-42
36810 - Anal Biochem. 1979 Jun;95(2):351-8
3219186 - Alcohol. 1988 Sep-Oct;5(5):387-91
14938361 - J Biol Chem. 1952 Mar;195(1):133-40
14492321 - J Ment Sci. 1962 Mar;108:134-46
4388022 - Anal Biochem. 1969 Mar;27(3):502-22
10807941 - Biochem Pharmacol. 2000 Jul 1;60(1):19-29
12788382 - J Mol Cell Cardiol. 2003 Jun;35(6):645-52
9012776 - Food Chem Toxicol. 1996 Oct;34(10):1003-7
19293034 - J Formos Med Assoc. 2009 Mar;108(3):195-201
10940340 - Annu Rev Nutr. 2000;20:395-430
16447273 - Hepatology. 2006 Feb;43(2 Suppl 1):S63-74
6342974 - Curr Concepts Nutr. 1983;12:49-71
6148299 - Hepatology. 1984 Sep-Oct;4(5):893-6
2806937 - Free Radic Biol Med. 1989;7(2):117-23
15763227 - Clin Liver Dis. 2005 Feb;9(1):1-35
16923312 - Proc Nutr Soc. 2006 Aug;65(3):278-90
15962320 - Hepatology. 2005 Jul;42(1):5-13
6421974 - J Lipid Res. 1983 Dec;24(12):1612-25
7771668 - Alcohol Clin Exp Res. 1995 Feb;19(1):81-91
16344593 - Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):102S-109S
16076762 - J Toxicol Environ Health A. 2005 Sep;68(17-18):1497-509
17854140 - World J Gastroenterol. 2007 Oct 7;13(37):4974-8
18045675 - Mol Aspects Med. 2008 Feb-Apr;29(1-2):9-16
References_xml – reference: 9875551 - Semin Liver Dis. 1998;18(4):313-29
– reference: 19293034 - J Formos Med Assoc. 2009 Mar;108(3):195-201
– reference: 14492321 - J Ment Sci. 1962 Mar;108:134-46
– reference: 17854140 - World J Gastroenterol. 2007 Oct 7;13(37):4974-8
– reference: 6733615 - Can Med Assoc J. 1984 Jun 1;130(11):1445-7
– reference: 16344593 - Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):102S-109S
– reference: 18045675 - Mol Aspects Med. 2008 Feb-Apr;29(1-2):9-16
– reference: 3172971 - Life Sci. 1988;43(12):991-8
– reference: 6148299 - Hepatology. 1984 Sep-Oct;4(5):893-6
– reference: 2169497 - J Infect Dis. 1990 Oct;162(4):817-22
– reference: 11886428 - Eur J Clin Invest. 2002 Mar;32 Suppl 1:21-7
– reference: 9397995 - Hepatology. 1997 Dec;26(6):1538-45
– reference: 10940340 - Annu Rev Nutr. 2000;20:395-430
– reference: 6421974 - J Lipid Res. 1983 Dec;24(12):1612-25
– reference: 15670660 - Alcohol. 2004 Aug;34(1):9-19
– reference: 16076762 - J Toxicol Environ Health A. 2005 Sep;68(17-18):1497-509
– reference: 3338721 - Hepatology. 1988 Jan-Feb;8(1):65-8
– reference: 8412153 - J Stud Alcohol. 1993 Sep;54(5):626-9
– reference: 15962320 - Hepatology. 2005 Jul;42(1):5-13
– reference: 18007552 - Ann Hepatol. 2007 Oct-Dec;6(4):227-32
– reference: 9553600 - Postgrad Med. 1998 Apr;103(4):261-4, 267-8, 273-5
– reference: 16377365 - Gen Hosp Psychiatry. 2006 Jan-Feb;28(1):48-54
– reference: 9581686 - Hepatology. 1998 May;27(5):1317-23
– reference: 10807941 - Biochem Pharmacol. 2000 Jul 1;60(1):19-29
– reference: 12788382 - J Mol Cell Cardiol. 2003 Jun;35(6):645-52
– reference: 8610707 - Am J Epidemiol. 1996 May 1;143(9):936-42
– reference: 3997068 - Hepatology. 1985 May-Jun;5(3):367-75
– reference: 1443441 - Alcohol Clin Exp Res. 1992 Oct;16(5):991-5
– reference: 9867111 - Scand J Gastroenterol Suppl. 1998;228:38-46
– reference: 16923312 - Proc Nutr Soc. 2006 Aug;65(3):278-90
– reference: 11966508 - Aliment Pharmacol Ther. 2002 May;16(5):985-92
– reference: 9012776 - Food Chem Toxicol. 1996 Oct;34(10):1003-7
– reference: 8030604 - Am J Clin Nutr. 1994 Aug;60(2):255-61
– reference: 3219186 - Alcohol. 1988 Sep-Oct;5(5):387-91
– reference: 7771668 - Alcohol Clin Exp Res. 1995 Feb;19(1):81-91
– reference: 12632815 - J Formos Med Assoc. 2002 Dec;101(12):826-34
– reference: 520102 - Dig Dis Sci. 1979 Nov;24(11):835-8
– reference: 6342974 - Curr Concepts Nutr. 1983;12:49-71
– reference: 9021946 - Hepatology. 1997 Feb;25(2):351-5
– reference: 3258084 - Acta Psychiatr Scand. 1988 Jan;77(1):7-13
– reference: 2627239 - Alcohol Alcohol. 1989;24(6):503-7
– reference: 17520517 - Semin Liver Dis. 2007 May;27(2):173-93
– reference: 16447273 - Hepatology. 2006 Feb;43(2 Suppl 1):S63-74
– reference: 4388022 - Anal Biochem. 1969 Mar;27(3):502-22
– reference: 14938361 - J Biol Chem. 1952 Mar;195(1):133-40
– reference: 2806937 - Free Radic Biol Med. 1989;7(2):117-23
– reference: 36810 - Anal Biochem. 1979 Jun;95(2):351-8
– reference: 15763227 - Clin Liver Dis. 2005 Feb;9(1):1-35
– reference: 8720922 - Free Radic Biol Med. 1996;20(3):483-8
– reference: 15670669 - Alcohol. 2004 Aug;34(1):81-7
SSID ssj0023352
Score 2.0978794
Snippet AIM:To investigate the antioxidative status of patients with alcoholic liver disease(ALD) in southeastern Taiwan.METHODS:Our study comprised 27 patients...
To investigate the antioxidative status of patients with alcoholic liver disease (ALD) in southeastern Taiwan. Our study comprised 27 patients with ALD...
To investigate the antioxidative status of patients with alcoholic liver disease (ALD) in southeastern Taiwan.AIMTo investigate the antioxidative status of...
AIM: To investigate the antioxidative status of patients with alcoholic liver disease (ALD) in southeastern Taiwan. METHODS: Our study comprised 27 patients...
SourceID pubmedcentral
proquest
pubmed
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1063
SubjectTerms Adult
Antioxidants - metabolism
Brief
Erythrocytes - metabolism
Ethnic Groups
Female
Glutathione - metabolism
GPX活性
Humans
Lipid Peroxidation
Liver Diseases, Alcoholic - blood
Liver Diseases, Alcoholic - enzymology
Male
Severity of Illness Index
Taiwan
Thiobarbituric Acid Reactive Substances - metabolism
东南部
台湾地区
患者
氧化状态
肝病
谷胱甘肽过氧化物酶
酒精性
Title Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan
URI http://lib.cqvip.com/qk/84123X/201108/37862201.html
https://www.ncbi.nlm.nih.gov/pubmed/21448360
https://www.proquest.com/docview/859497410
https://pubmed.ncbi.nlm.nih.gov/PMC3057151
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2219-2840
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0023352
  issn: 1007-9327
  databaseCode: DIK
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2219-2840
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0023352
  issn: 1007-9327
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2219-2840
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0023352
  issn: 1007-9327
  databaseCode: RPM
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaq5cIFgXh1ecgHbsihSZzXcVWBVlWLOHTF7qlybKcbBMnSbXZX_CR-JTO282jpAfYSValdp54v9sx45htC3sUBl5LHE5YJFTKu4CJimbEIRCxUFurcBNEsPsenZ3x2Hp2PRr8HUUvNNvfkr4N5JfeRKtwDuWKW7H9ItvtRuAGfQb5wBQnD9Z9kfIKhinelsuTdmBvUmMgMR5baZq7ZKrilfP8dgzDaMxn0dFxjAT2s3oP10JaivHVYcdqqjbQZkEusoemmRhrPjeVuQofC11lXn2vqcj0uBJu3e-Lg9rxks6b3nZYbG7hfrdms7ltfCOO-XeiSzd3zqN7P2qV5G98bFo_Gsqjrv_xpsNJ5dsy9DC4M2GCgTyY7q3MyQGE6WGrBlg0H2zaYsZNDWwLS64Acb7-tvRs_8crUazsOAHL1wyAE6eMwqaXfG7uIxS-LKayMiY_Z-g8C2EEmrWfIGfeYu2ZO1t1_sDRSOPqHvbEN_7QdCAk9LmGCf8LkHDJx9iN1B6rP8jF55GwWemIB-ISMdPWULHfARy34aF3QFnwUwUc78FEDPurAR8uKDsFHLfiekbNPH5fTU-ZKdDAZZP6WpYEvZBYprrO0UBqsb3jl_bjIU4FMgVJj_TNfg14vokKD6p0mSS6LhEsueJH74XNyVNWVfkkoD7jSHKAUp4pHkchiDapzpjINelyu9Jgcd3O1urJULKswAYsc-owJbSdvBesjHnqJStfN9SqNMg42sz8Zkxd2LrvOrRTGJNmZ5a4BUq_vflOVl4aC3WHh-N49X5GH_VvzmhxtN41-A-rtNn9rcPUHM7asQQ
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antioxidative+status+of+patients+with+alcoholic+liver+disease+in+southeastern+Taiwan&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Chen%2C+Ya-Ling&rft.au=Chen%2C+Li-Ju&rft.au=Bair%2C+Ming-Jong&rft.au=Yao%2C+Mei-Lan&rft.date=2011-02-28&rft.pub=Baishideng+Publishing+Group+Co.%2C+Limited&rft.issn=1007-9327&rft.volume=17&rft.issue=8&rft.spage=1063&rft.epage=1070&rft_id=info:doi/10.3748%2Fwjg.v17.i8.1063&rft_id=info%3Apmid%2F21448360&rft.externalDocID=PMC3057151
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg